Dexcom is poised to share new data on the benefits of its continuous glucose monitoring technology (CGM), which the company says reinforces the need to broaden CGM access beyond insulin-treated ...
Dexcom reaffirms CGM benefits for all people with diabetes and continues momentum towards earlier stage intervention and ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and ...
CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on ...